111
TITLE: Natural history and survival in stage 1 Val30Met transthyretin familial amyloid polyneuropathy
AUTHORS: Coelho, T; Ines, M; Conceicao, I; Soares, M; de Carvalho, M; Costa, J;
PUBLISHED: 2018, SOURCE: NEUROLOGY, VOLUME: 91, ISSUE: 21
INDEXED IN: WOS CrossRef: 65
IN MY: ORCID
112
TITLE: Non-adenomatous sellar lesions: single-centre 10-year experience
AUTHORS: Santos, FS; Dias, LN; Henriques, V; Marques, CC; Chorao, M; Duarte, JS; Limbert, C; Costa, J; Graca, J; Vasconcelos, C; Cabral, J; Ramos, S;
PUBLISHED: 2018, SOURCE: HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, VOLUME: 17, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef: 4
IN MY: ORCID
113
TITLE: Endotherapy of infected grapevine cuttings for the control of Phaeomoniella chlamydospora and Phaeoacremonium minimum  Full Text
AUTHORS: Giovanni Del Frari; Joao Costa; Helena Oliveira; Ricardo Boavida Ferreira;
PUBLISHED: 2018, SOURCE: PHYTOPATHOLOGIA MEDITERRANEA, VOLUME: 57, ISSUE: 3
INDEXED IN: Scopus WOS
114
TITLE: Adverse events with botulinum toxin treatment in cervical dystonia: How much should we blame placebo?
AUTHORS: Duarte, GS; Rodrigues, FB; Ferreira, JJ; Costa, J;
PUBLISHED: 2018, SOURCE: PARKINSONISM & RELATED DISORDERS, VOLUME: 56
INDEXED IN: WOS CrossRef: 11
IN MY: ORCID
115
TITLE: Electrochemical skin conductance in hereditary amyloidosis related to transthyretin V30M-a promising tool to assess treatment efficacy?
AUTHORS: Castro, J; Costa, J; de Castro, I; Conceicao, I;
PUBLISHED: 2018, SOURCE: AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, VOLUME: 25, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef: 5
IN MY: ORCID
116
TITLE: COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN FOR THE TREATMENT OF SYMPTOMATIC CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION IN PORTUGAL
AUTHORS: Alarcao, J; Ascencao, R; Costa, J; Gouveia, M; Borges, M;
PUBLISHED: 2018, SOURCE: VALUE IN HEALTH, VOLUME: 21
INDEXED IN: WOS CrossRef
IN MY: ORCID
117
TITLE: REAL WORLD EVIDENCE ON TYPE 2 DIABETES: IDENTIFICATION AND CHARACTERIZATION OF NON-INSULIN TREATED PATIENTS WHO FULFIL CONDITIONS FOR THAT TREATMENT
AUTHORS: Ascencao, R; Fiorentino, F; Costa, J; Gouveia, M; Borges, M;
PUBLISHED: 2018, SOURCE: VALUE IN HEALTH, VOLUME: 21
INDEXED IN: WOS CrossRef
IN MY: ORCID
118
TITLE: IMPACT OF TRANSFERRING ARTS DISPENSING FROM HOSPITAL TO COMMUNITY PHARMACIES: A PILOT STUDY IN PORTUGAL
AUTHORS: Borges, M; Gouveia, M; Costa, J; Fiorentino, F; Sousa, R; Jesus, G; Rodrigues, AT; Cary, M; Guerreiro, JP; Heudtlass, P; Costa, S; Carneiro, AV;
PUBLISHED: 2018, SOURCE: VALUE IN HEALTH, VOLUME: 21
INDEXED IN: WOS CrossRef: 1
IN MY: ORCID
119
TITLE: INSULIN GAP IN TYPE 2 DIABETES: IS IT COST EFFECTIVE TO INTENSIFY TREATMENT? EVIDENCE FROM PORTUGAL USING REAL WORLD DATA
AUTHORS: Fiorentino, F; Ascencao, R; Costa, J; Gouveia, M; Borges, M;
PUBLISHED: 2018, SOURCE: VALUE IN HEALTH, VOLUME: 21
INDEXED IN: WOS CrossRef
IN MY: ORCID
120
TITLE: BURDEN AND COSTS OF ACUTE MYELOID LEUKAEMIA IN PORTUGAL
AUTHORS: Guerreiro, R; Silva, ML; Costa, J; Paquete, AT; Alarcao, J; Fiorentino, F; Borges, M;
PUBLISHED: 2018, SOURCE: VALUE IN HEALTH, VOLUME: 21
INDEXED IN: WOS CrossRef
IN MY: ORCID
Page 12 of 34. Total results: 334.